查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
血浆蛋白治疗市场，按产品类型、按应用、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1419029

血浆蛋白治疗市场，按产品类型、按应用、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Plasma Protein Therapeutic Market, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 291 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023 年血浆蛋白治疗市场规模为 300.53 亿美元，2024 年至 2032 年CAGR为 6.5%。

血浆蛋白治疗市场-市场动态

自体免疫疾病、免疫缺陷性疾病、神经系统和出血性疾病的增加预计将推动市场的成长。

血浆蛋白治疗剂，例如血浆源性免疫球蛋白，用于治疗特定的自体免疫疾病。自体免疫疾病盛行率的上升导致对血浆疗法的需求不断增加，从而推动市场扩张。根据从斯堪的纳维亚国家等流行病学资源丰富的国家收集的综合研究和资料，估计自体免疫疾病总共影响约 3% 的美国人口，相当于约 1000 万人。为了更好地理解这一估计，考虑到美国目前的人口为 3.29 亿。此外，预计市场上免疫缺陷性疾病、神经系统疾病和出血性疾病的发生率将激增，从而导致需要治疗干预的患者数量增加。神经系统疾病的流行尤其会推动对这些治疗方案的需求。全国不同地区各种神经系统疾病的盛行率从每10万人口967例到4070例不等，平均为2394例，显示超过3000万人患有神经系统疾病。此外，治疗技术的不断进步，例如重组蛋白和工程血浆蛋白的开发，为市场创新提供了机会。然而，值得注意的是，高昂的治疗成本以及潜在的污染和传播风险可能会阻碍市场的成长。

血浆蛋白治疗市场 - 关键见解

  • 根据我们的研究分析师分享的分析，预计全球血浆蛋白治疗市场在预测期内（2024-2032）每年将以 6.5% 左右的CAGR成长
  • 根据产品类型细分，预计免疫球蛋白将在 2023 年显示最大的市场份额
  • 根据应用细分，原发性免疫缺陷症（PIDD）是 2023 年的主导类型
  • 按地区划分，亚太地区是 2023 年的主要收入来源

血浆蛋白治疗市场-細項分析：

全球血浆蛋白治疗市场根据产品类型、应用和地区进行细分。

根据产品类型，市场分为三类：白蛋白、免疫球蛋白、血浆衍生因子 VIII 和其他。市场在很大程度上受到免疫球蛋白领域主导地位的影响。免疫球蛋白产品在血浆蛋白治疗市场中具有重要意义，因为它们对于治疗免疫缺陷性疾病、自体免疫疾病和神经系统疾病等一系列疾病至关重要。

根据应用，市场分为两类：血友病、原发性免疫缺陷症（PIDD）、特发性血小板减少性紫斑症（ITP）和其他。该市场主要由原发性免疫缺陷症（PIDD）细分市场主导。在免疫系统受损的 PIDD 病例中，患者经常会出现抗体缺乏的情况。免疫球蛋白替代疗法源自人类血浆，在 PIDD 的治疗中发挥着至关重要的作用。这种疗法需要施用免疫球蛋白来增强患者的免疫反应。

血浆蛋白治疗市场 - 地理洞察

从地理来看，该市场遍布北美、拉丁美洲、欧洲、亚太、中东和非洲等多个地区。这些区域根据参与商业活动的国家进一步划分。预计该市场的成长将由亚太地区主导，这主要是由于其完善的医疗基础设施以及市场参与者在血浆蛋白疗法研发方面的集中努力。近年来，亚太地区医疗基础建设显着成长，医疗设施、医院、研究中心等方面的投资不断增多，促进了医疗生态系统的整体改善。值得注意的是，中国政府已经成功建立了健全的医疗保健体系，考虑到中国作为世界上最大的发展中国家的地位，这是相当具有挑战性的。经过历届政府的持续努力，预计到2021年底，中国内地医疗卫生机构总数将达到1030935个，其中医院36570个，基层诊所977790个。就市场规模而言，由于对先进治疗方案的需求不断增长以及发展中经济体的成长，欧洲在预测期内占据第二大地位。

血浆蛋白治疗市场-竞争格局：

与传统製药业不同，血浆产业利用人体血浆（一种活细胞）作为生产救命药物的主要材料。这些药物的生产依赖于有限的原材料供应，与生物技术设施中生长的非生命分子和生物製剂相比，原材料的获取通常更加昂贵且复杂。为了保持市场竞争力，持续的研究和开发工作至关重要。公司将投资用于开发新的和改进的血浆衍生产品、改进製造流程以及探索新的治疗应用。生物技术的进步，例如重组蛋白的创建，是许多公司关注的领域，因为他们努力满足对更安全、更永续的治疗方案日益增长的需求。具有全球影响力的公司在进入多元化市场方面具有优势。他们建立製造设施、分销网络和合作伙伴关係，以确保其产品在各个地区的供应。随着血浆衍生疗法的需求持续上升，公司可能会坚持投资研发、探索策略合作伙伴关係并适应不断变化的市场动态，以保持竞争优势。

最新进展：

到 2023 年 5 月，Biotest AG 获得了在另外 5 个国家销售 Cytotect（一种 CMV 超级免疫球蛋白）的营销授权，其市场现已覆盖 28 个国家：捷克共和国、斯洛伐克、立陶宛、爱尔兰和罗马尼亚。

目录

第一章：血浆蛋白治疗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的血浆蛋白治疗市场片段
    • 血浆蛋白治疗市场片段（依应用）
    • 按国家/地区分類的血浆蛋白治疗市场片段
    • 按地区分類的血浆蛋白治疗市场片段
  • 竞争洞察

第 3 章：血浆蛋白治疗主要市场趋势

  • 血浆蛋白治疗市场驱动因素
    • 市场驱动因素的影响分析
  • 血浆蛋白治疗市场限制
    • 市场限制影响分析
  • 血浆蛋白治疗市场机会
  • 血浆蛋白治疗市场未来趋势

第 4 章：血浆蛋白治疗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：血浆蛋白治疗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：血浆蛋白治疗市场格局

  • 2022 年血浆蛋白治疗市占分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：血浆蛋白治疗市场 - 依产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 白蛋白
    • 免疫球蛋白
    • 血浆衍生因子 VIII
    • 其他的

第 8 章：血浆蛋白治疗市场 -按应用

  • 概述
    • 按应用的细分市场占有率分析
    • 血友病
    • 原发性免疫缺陷症 (PIDD)
    • 特发性血小板减少性紫斑症 (ITP)
    • 其他的

第 9 章：血浆蛋白治疗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美血浆蛋白治疗主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按应用）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲血浆蛋白治疗主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按应用）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区血浆蛋白治疗主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模与预测（按应用）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲血浆蛋白治疗主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲血浆蛋白治疗主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按应用）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 10 章：主要供应商分析 - 血浆蛋白治疗产业

  • 竞争仪表板
  • 公司简介
    • CSL
    • Grifols, SA
    • Takeda
    • Octapharma AG
    • Biotest AG
    • Kedrion SpA

第 11 章：360 度分析师视角

第 12 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2094

REPORT HIGHLIGHT

Plasma Protein Therapeutic Market size was valued at USD 30,053 Million in 2023, expanding at a CAGR of 6.5% from 2024 to 2032.

Plasma protein therapies are exceptional biologic medications that are administered through infusion or injection to address a diverse range of uncommon, life-threatening, chronic, and genetic ailments. These conditions encompass bleeding disorders, immune deficiencies, pulmonary disorders, neurological disorders, shock and trauma, liver cirrhosis, as well as infectious diseases like tetanus, hepatitis, and rabies. The utilization of plasma-derived medicines is crucial for patients suffering from rare diseases that can solely be managed through these therapies. Moreover, these medicines play a vital role in everyday medical practices, emergency and critical care scenarios, and preventive medicine. On a daily basis, approximately 300,000 European patients heavily rely on plasma protein therapies to effectively treat various critical medical conditions. These conditions may include rare genetic diseases, chronic ailments, or life-threatening medical emergencies resulting from accidents and trauma. For these patients, plasma-derived medicines serve as a lifeline by aiding the body in replacing missing or deficient proteins. The absence of consistent access to these treatments would result in the loss of many lives or a significant decline in the quality of life for these individuals.

Plasma Protein Therapeutic Market- Market Dynamics

Increase in autoimmune disorders, immune deficiency disorders, neurological and bleeding disorders are projected to drive the growth of market.

Plasma protein therapeutics, such as plasma-derived immunoglobulins, are utilized in the treatment of specific autoimmune disorders. The rising prevalence of autoimmune diseases contributes to the increasing demand for plasma-based therapies, thereby propelling market expansion. Based on comprehensive research and data collected from countries with robust epidemiological resources, such as the Scandinavian countries, it is estimated that autoimmune diseases collectively affect approximately 3% of the US population, equivalent to around 10 million individuals. To better comprehend this estimation considers the current US population of 329 million. Additionally, the market is expected to witness a surge in the incidence of immune deficiency disorders, neurological disorders, and bleeding disorders, resulting in a larger patient pool necessitating therapeutic interventions. The prevalence of neurological disorders specifically can drive the demand for these therapeutic options. The prevalence rates of various neurological disorders across different regions of the country range from 967 to 4,070 per 100,000 population, with an average of 2,394, indicating that over 30 million people are affected by neurological disorders. Moreover, ongoing advancements in therapeutic technologies, such as the development of recombinant proteins and engineered plasma proteins, present opportunities for innovation within the market. However, it is important to note that the high cost of treatment and the potential risks of contamination and transmission may impede the growth of the market.

Plasma Protein Therapeutic Market- Key Insights

  • As per the analysis shared by our research analyst, the global Plasma Protein Therapeutic market is estimated to grow annually at a CAGR of around 6.5% over the forecast period (2024-2032)
  • Based on product type segmentation, Immunoglobulin was predicted to show maximum market share in the year 2023
  • Based on application segmentation, Primary Immunodeficiency Disorder (PIDD) was the leading type in 2023
  • On the basis of region, Asia pacific was the leading revenue generator in 2023

Plasma Protein Therapeutic Market- Segmentation Analysis:

The Global Plasma Protein Therapeutic Market is segmented on the basis of Product Type, Application and Region.

The market is divided into three categories based on product type: Albumin, Immunoglobulin, Plasma-derived Factor VIII and Others. The market is largely influenced by the dominance of the Immunoglobulin segment. Immunoglobulin products hold significant importance in the Plasma Protein Therapeutic market as they are vital in treating a range of medical conditions such as immunodeficiency disorders, autoimmune diseases, and neurological disorders.

The market is divided into two categories based on application: Hemophilia, Primary Immunodeficiency Disorder (PIDD), Idiopathic Thrombocytopenic Purpura (ITP) and Others. The market is primarily dominated by the segment of Primary Immunodeficiency Disorder (PIDD). In cases of PIDD, where the immune system is compromised, patients frequently experience a deficiency in antibodies. Immunoglobulin Replacement Therapy, which is derived from human plasma, plays a crucial role in the management of PIDD. This therapy entails the administration of immunoglobulins to bolster the patient's immune response.

Plasma Protein Therapeutic Market- Geographical Insights

Geographically, this market is spread across various regions including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The growth of the market is expected to be dominated by the Asia Pacific region, primarily due to its well-established healthcare infrastructure and the focused efforts of market players in research and development for plasma protein therapeutics. In recent years, Asia Pacific has witnessed significant growth in its healthcare infrastructure, with investments being made in medical facilities, hospitals, and research centers, thereby contributing to the overall improvement of the healthcare ecosystem. Notably, the Chinese government has successfully established a robust healthcare system, which is quite challenging considering the country's status as the largest developing nation in the world. Through continuous efforts of successive governments, the Chinese mainland is projected to have a total of 1,030,935 healthcare institutions by the end of 2021, including 36,570 hospitals and 977,790 primary-level clinics. In terms of market size, Europe holds the second-largest position during the forecast period, driven by the increasing demand for advanced treatment options and the growth of developing economies.

Plasma Protein Therapeutic Market- Competitive Landscape:

In contrast to the conventional pharmaceutical industry, the plasma industry utilizes human blood plasma, a living cell, as its primary material for producing life-saving medications. The production of these medications relies on a limited supply of raw material, which is generally more expensive and complex to obtain compared to non-living molecules and biologics grown in biotechnology facilities. To remain competitive in the market, ongoing research and development efforts are crucial. Companies allocate investments towards the development of new and improved plasma-derived products, the enhancement of manufacturing processes, and the exploration of new therapeutic applications. Biotechnology advancements, such as the creation of recombinant proteins, are areas of focus for many companies as they strive to meet the increasing demand for safer and more sustainable treatment options. Companies with a global presence have an advantage in accessing diverse markets. They establish manufacturing facilities, distribution networks, and partnerships to ensure the availability of their products in various regions. As the demand for plasma-derived therapies continues to rise, companies are likely to persist in investing in research and development, exploring strategic partnerships, and adapting to evolving market dynamics to maintain their competitive edge.

Recent Advancements:

In May 2023, Biotest AG now has 28 nations on its market due to marketing authorizations it was granted to sell Cytotect, a CMV-hyper immunoglobulin, in five more countries: the Czech Republic, Slovakia, Lituania, Ireland, and Romania.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PLASMA PROTEIN THERAPEUTIC MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • CSL
  • Grifols, S.A.
  • Takeda
  • Octapharma AG
  • Biotest AG
  • Kedrion S.p.A

GLOBAL PLASMA PROTEIN THERAPEUTIC MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Albumin
  • Immunoglobulin
  • Plasma-derived Factor VIII
  • Others

GLOBAL PLASMA PROTEIN THERAPEUTIC MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Hemophilia
  • Primary Immunodeficiency Disorder (PIDD)
  • Idiopathic Thrombocytopenic Purpura (ITP)
  • Others

GLOBAL PLASMA PROTEIN THERAPEUTIC MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Plasma Protein Therapeutic Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Plasma Protein Therapeutic Market Snippet by Product Type
    • 2.1.2. Plasma Protein Therapeutic Market Snippet by Application
    • 2.1.3. Plasma Protein Therapeutic Market Snippet by Country
    • 2.1.4. Plasma Protein Therapeutic Market Snippet by Region
  • 2.2. Competitive Insights

3. Plasma Protein Therapeutic Key Market Trends

  • 3.1. Plasma Protein Therapeutic Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Plasma Protein Therapeutic Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Plasma Protein Therapeutic Market Opportunities
  • 3.4. Plasma Protein Therapeutic Market Future Trends

4. Plasma Protein Therapeutic Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Plasma Protein Therapeutic Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Plasma Protein Therapeutic Market Landscape

  • 6.1. Plasma Protein Therapeutic Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Plasma Protein Therapeutic Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Albumin
    • 7.1.3. Immunoglobulin
    • 7.1.4. Plasma-derived Factor VIII
    • 7.1.5. Others

8. Plasma Protein Therapeutic Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Hemophilia
    • 8.1.3. Primary Immunodeficiency Disorder (PIDD)
    • 8.1.4. Idiopathic Thrombocytopenic Purpura (ITP)
    • 8.1.5. Others

9. Plasma Protein Therapeutic Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Plasma Protein Therapeutic Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Plasma Protein Therapeutic Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Plasma Protein Therapeutic Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Plasma Protein Therapeutic Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Plasma Protein Therapeutic Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Plasma Protein Therapeutic Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. CSL
    • 10.2.2. Grifols, S.A.
    • 10.2.3. Takeda
    • 10.2.4. Octapharma AG
    • 10.2.5. Biotest AG
    • 10.2.6. Kedrion S.p.A

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Plasma Protein Therapeutic Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Plasma Protein Therapeutic Market, by Product Type 2018-2030 (USD Million)
  • TABLE Plasma Protein Therapeutic Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Plasma Protein Therapeutic Market, by Application 2018-2030 (USD Million)
  • TABLE Plasma Protein Therapeutic Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Plasma Protein Therapeutic Market, by Region 2018-2030 (USD Million)
  • TABLE North America Plasma Protein Therapeutic Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Plasma Protein Therapeutic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Plasma Protein Therapeutic Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Plasma Protein Therapeutic Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Plasma Protein Therapeutic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Plasma Protein Therapeutic Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Plasma Protein Therapeutic Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Plasma Protein Therapeutic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Plasma Protein Therapeutic Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Plasma Protein Therapeutic Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Plasma Protein Therapeutic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Plasma Protein Therapeutic Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Plasma Protein Therapeutic Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Plasma Protein Therapeutic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Plasma Protein Therapeutic Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Plasma Protein Therapeutic Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product Type segment market share analysis, 2022 & 2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Plasma Protein Therapeutic Market share and leading players, 2022
  • FIGURE Europe Plasma Protein Therapeutic Market share and leading players, 2022
  • FIGURE Asia Pacific Plasma Protein Therapeutic Market share and leading players, 2022
  • FIGURE Latin America Plasma Protein Therapeutic Market share and leading players, 2022
  • FIGURE Middle East and Africa Plasma Protein Therapeutic Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Plasma Protein Therapeutic Market share analysis by country, 2022
  • FIGURE Germany Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Plasma Protein Therapeutic Market share analysis by country, 2022
  • FIGURE India Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Plasma Protein Therapeutic Market share analysis by country, 2022
  • FIGURE Brazil Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Plasma Protein Therapeutic Market share analysis by country, 2022
  • FIGURE Saudi Arabia Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)